- Home
- YQ vs PRPH Comparison
YQ vs PRPH Comparison
Compare YQ & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YQ
- PRPH
- Stock Information
- Founded
- YQ 2012
- PRPH 1989
- Country
- YQ China
- PRPH United States
- Employees
- YQ N/A
- PRPH N/A
- Industry
- YQ Other Consumer Services
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- YQ Real Estate
- PRPH Health Care
- Exchange
- YQ Nasdaq
- PRPH Nasdaq
- Market Cap
- YQ 13.1M
- PRPH 15.5M
- IPO Year
- YQ 2020
- PRPH 1997
- Fundamental
- Price
- YQ $1.63
- PRPH $0.70
- Analyst Decision
- YQ
- PRPH Strong Buy
- Analyst Count
- YQ 0
- PRPH 1
- Target Price
- YQ N/A
- PRPH $11.00
- AVG Volume (30 Days)
- YQ 42.7K
- PRPH 232.3K
- Earning Date
- YQ 12-11-2024
- PRPH 11-13-2024
- Dividend Yield
- YQ N/A
- PRPH N/A
- EPS Growth
- YQ N/A
- PRPH N/A
- EPS
- YQ N/A
- PRPH N/A
- Revenue
- YQ $28,507,378.00
- PRPH $12,753,000.00
- Revenue This Year
- YQ N/A
- PRPH $36.93
- Revenue Next Year
- YQ N/A
- PRPH $132.05
- P/E Ratio
- YQ N/A
- PRPH N/A
- Revenue Growth
- YQ 22.55
- PRPH N/A
- 52 Week Low
- YQ $1.47
- PRPH $0.64
- 52 Week High
- YQ $3.55
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- YQ 31.56
- PRPH 28.79
- Support Level
- YQ $1.50
- PRPH $0.66
- Resistance Level
- YQ $1.92
- PRPH $0.74
- Average True Range (ATR)
- YQ 0.20
- PRPH 0.06
- MACD
- YQ -0.01
- PRPH 0.05
- Stochastic Oscillator
- YQ 16.13
- PRPH 34.44
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.